Biohaven Pharmaceutical Holding Company Ltd.

NYSE:BHVN

39.31 (USD) • At close February 4, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q12019 Q42019 Q12018 Q42018 Q22018 Q12017 Q1
Operating Activities:
Net Income -160.304-319.771-179.504-144.756-102.574-90.346-70.492-201.107-68.854-203.287-97.032-51.886-54.365-53.773-53.773-533.374-172.937-381.039-62.304-136.7070-85.462-18.753
Depreciation & Amortization 3.4761.9540.9410.9481.5381.8311.6490.3440.3770.4150.250.6850.2260.2410.2419.4470-0.0170-0.02100.0170.004
Deferred Income Tax 000-17.76700067.637-67.63700-40.3210040.321004.22406.880-4.224-2.656
Stock Based Compensation 12.1612.23234.87715.8714.4564.6953.765115.62916.99720.8140.1212.96815.39318.63918.63933.20516.87944.5547.3311.95103.0881.886
Change In Working Capital -2.309-23.30925.618-8.7172.78141.363-10.814-0.999-44.0820.179-3.7036.635-8.672-0.94-0.94-3.9876.529-1.682-2.542-6.8804.2242.656
Accounts Receivables 000000044.1800-20.073-147.16300-36.658-115.774-4.337000000
Change In Inventory 000000029.08800-23.397-2.92700-17.566-34.356-3.609000000
Change In Accounts Payables 2.485-19.12619.0666.062-2.524-2.4173.7535.972-1.646-0.3251.927-2.48-2.076013.90320.87414.4751.637-2.542-1.4904.2242.656
Other Working Capital -4.794-4.18325.618-14.7795.30543.78-3.753-80.239-42.43420.50437.849.115-6.596-0.94-0.943.987-6.5291.6822.5426.880-4.224-2.656
Other Non Cash Items 5.701161.09652.1939.54-1.014-1.936-1.746-56.91167.63793.9971.529-1.4583.6871.3061.306-10.579-1.19385.03110.64716.82100.8249.211
Operating Cash Flow -141.276-167.798-102.637-114.881-94.813-44.393-77.638-75.407-95.56-67.886-58.836-33.056-43.731-34.527-34.527-505.288-150.722-248.929-46.869-107.9560-81.533-7.652
Investing Activities:
Investments In Property Plant And Equipment -0.611-2.949-0.44-0.47-1.248-0.595-0.735-0.3-4.524-36.004-0.246-0.201-0.031-0.353-0.353-0.316-1.016-1.139-1.038-3.7870-0.357-0.021
Acquisitions Net -0.39100.39100-0.077000-350000.9410.94100000000
Purchases Of Investments -222.787-196.182-47.084-111.299-29.45-23.55-29.822-12.900-246.816-193.295000-319.39501.3750-3.3760-1.375-1.624
Sales Maturities Of Investments 130101.281.164107.85589.247100.39929.498-116.908003.058100.60900120.95694.9850000000
Other Investing Activites 0.39100.391-3.44459.7970.077-0-133.90800243.75822.35000-20.75-22.35-1.250-0.067000.067
Investing Cash Flow -93.398-97.93134.031-3.91458.54976.254-1.059-264.016-4.524-36.004-0.246-0.201-0.0310.5880.588-245.476-23.366-1.014-1.038-7.230-1.732-1.578
Financing Activities:
Debt Repayment 00000000000000000000000
Common Stock Issued 76.361320.8852.203247.1200045.387127.543109.87400000000043.953000
Common Stock Repurchased 00000000000000000000000
Dividends Paid 00000000000000000000000
Other Financing Activities 4.014321.1233.423-37.069-39.656-20.33926.668530.18127.54386.84123.033-252.385315.04137.896421.015502.159285.6377.5251.065246.508056.00337.951
Financing Cash Flow 80.375321.1233.423210.051-39.656-20.33926.668530.18127.54386.84123.033-252.385315.04137.89637.896502.159285.6377.5251.065246.508056.00337.951
Other Information:
Effect Of Forex Changes On Cash 0-0.007-0.006-0.31-0.04-0.1620.0152.72200-0.046-43.96543.76200.0140.4390000000
Net Change In Cash -154.29954.797-65.214126.105-75.9611.36-52.014191.18627.459-17.049-36.049-285.642271.2793.957335.124-295.008111.512100.32-46.842131.3220-27.26228.721
Cash At End Of Period 88.019239.303184.506249.72125.99201.95190.59242.60451.41823.95941.00877.057362.69991.42469.355134.231429.239317.727217.407264.2490104.20652.286